RECENT NEWS

As part of its commitment to achieving equitable health security outcomes, the UK Health Security Agency has published comprehensive new data, which shows there are stark social divides in infectious disease admission rates.

A new study published by the UK Health Security Agency (UKHSA) shows that some bacteria have already become resistant to one of the newest antibiotics introduced to the NHS.

​A new daily pill for endometriosis has been approved for use on the NHS and could help over a thousand women in England every year manage the symptoms of the debilitating condition.

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia.

Developed by The Howard de Walden Estate and operated in partnership with Spacemade, Hale House is set to position the Harley Street Health District as a leading cluster for Health innovation.

People are far more accepting of AI being used in the NHS when they are familiar with AI in general, showing the need for greater public engagement, according to a survey of public attitudes to AI in healthcare conducted by J.L. Partners on behalf of the Royal College of Radiologists (RCR).

Innovative West Midlands health tech companies showcased their new developments, including an AI-powered sensor to be used after surgery to reduce hospital stays, to leading regional political figures.

Over 900 genetic links to osteoarthritis, including 500 that have never been reported before, have been uncovered in breakthrough research involving Sheffield Teaching Hospitals NHS Foundation Trust.

NHS clinicians will be supported to use ground-breaking AI tools that take notes, to free up staff time and deliver better care to patients, and the technology is being supported by new guidance from the government.

A bacteria killing coating created by scientists has been used in trials of a new paint that can be applied to a range of surfaces to effectively kill bacteria and viruses, including difficult to kill species such as MRSA, flu and COVID-19.

Immunisation efforts are under growing threat as misinformation, population growth, humanitarian crises and funding cuts jeopardise progress and leave millions of children, adolescents and adults at risk, warn WHO, UNICEF, and Gavi during World Immunisation Week, 24–30 April.

In a new study, published in The Lancet Neurology, researchers have found that using the Carotid Artery Risk (CAR) scoring system can help identify patients who can be effectively treated with a combination of medications and lifestyle changes tailored to their individual risk factors (otherwise known as optimised medical therapy).

The government is calling for men of all ages to come forward and feed into England’s first ever men’s health strategy.

Patients could soon benefit from world-leading technology to diagnose bowel cancer earlier, faster and cheaper, reducing the need for invasive colonoscopies and biopsies, and potentially saving valuable time and resource for the NHS, the government has announced.

Knowlex is hosting four essential conferences dedicated to advancing healthcare through infection prevention, patient safety, and innovation.

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease.

Childhood exposure to a toxin produced by E. coli could be contributing to the rise of bowel cancer in under-50s, according to research funded by Cancer Research UK.

A 12-month roll-out has commenced to deliver the most significant update to UK clinical trials regulation in two decades – with the aim of strengthening patient safety, accelerating approvals, enabling innovation and helping more people benefit from taking part in vital research.

​Scientists from Northwestern University, in the US, have identified that piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment.

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, could provide a solution to problems with current TB screening, which does not always accurately detect disease.